Gene Delivery Technologies Market 2024 Industry Analysis, History, Overviews, Value, Supply, and Forecast 2034

The global Gene Delivery Technologies Market is undergoing rapid expansion, driven by the increasing demand for advanced genetic therapies and precision medicine. The market is projected to grow from USD 5.20 billion in 2024 to USD 14.30 billion by 2034, registering a strong CAGR of 11.90% over the forecast period. This growth reflects the rising importance of gene-based treatment approaches in modern healthcare.

To receive a PDF sample of the report, visit @ https://www.emergenresearch.com/request-free-sample/4288

The Nuclear Medicine Market is a strategically important segment within the global diagnostic imaging and targeted therapy landscape, centered on the use of radiopharmaceuticals for disease detection, functional assessment, treatment planning, and increasingly, precision-guided therapy. Nuclear medicine plays a critical role across oncology, cardiology, neurology, endocrinology, and selected inflammatory and metabolic disorders, with its top applications spanning PET and SPECT imaging, hybrid modalities such as PET/CT and SPECT/CT, thyroid-related procedures, and a growing range of radiopharmaceutical therapies. The principal end-use settings include hospitals, specialty imaging centers, academic medical institutions, oncology networks, and nuclear pharmacies supporting time-sensitive preparation and distribution. Recent market trends highlight the continued rise of theranostics, where paired diagnostic and therapeutic radiopharmaceuticals are used to identify and treat specific disease targets, alongside the broader clinical adoption of hybrid imaging systems that combine anatomical and functional information. The market is also benefiting from expanding use of molecular imaging in oncology care pathways, deeper interest in radioligand therapy, and stronger alignment with precision medicine approaches.